Combination of nanoparticles with physical stimuli toward cancer therapy
- PMID: 24492718
- DOI: 10.1248/bpb.b13-00703
Combination of nanoparticles with physical stimuli toward cancer therapy
Abstract
Drug delivery systems represent an important strategy for cancer treatment. The targeted delivery of drugs is required for effective and safe cancer therapy. In cancer therapy, the target cells include cancer cells and immunocompetent cells such as antigen presenting cells. Anticancer drugs utilized include small molecular drugs, proteins and nucleic acid medicines. In order to deliver these drugs into the target cells, various nanoparticles have been developed. However, the efficacy of the nanoparticulate system itself is generally insufficient for the safe and effective treatment of cancer. For example, polyethylene glycol (PEG)-modified (PEGylated) nanoparticles accumulate in cancerous tissues; however, the PEG moiety on the surface of the nanoparticles disturbs cellular uptake, which is known as the 'PEG dilemma.' Thus, additional strategies such as receptor-mediated targeting are necessary to improve the delivery and cellular uptake of nanoparticles. Among additional strategies, in this review we have focused on the combination of nanoparticles with various physical stimuli, such as electric pulse and ultrasound, to improve the targeted delivery of the nanoparticles.
Similar articles
-
Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy.Colloids Surf B Biointerfaces. 2015 Nov 1;135:56-72. doi: 10.1016/j.colsurfb.2015.07.013. Epub 2015 Jul 18. Colloids Surf B Biointerfaces. 2015. PMID: 26241917 Review.
-
Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.Int J Nanomedicine. 2015 Mar 5;10:1791-804. doi: 10.2147/IJN.S75186. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25784805 Free PMC article.
-
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.Pharm Res. 2007 Aug;24(8):1405-14. doi: 10.1007/s11095-007-9284-6. Epub 2007 Mar 29. Pharm Res. 2007. PMID: 17393074 Review.
-
Role of integrated cancer nanomedicine in overcoming drug resistance.Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Adv Drug Deliv Rev. 2013. PMID: 23880506 Review.
-
Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry.J Control Release. 2015 May 28;206:67-74. doi: 10.1016/j.jconrel.2015.03.011. Epub 2015 Mar 12. J Control Release. 2015. PMID: 25770398
Cited by
-
PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.Int J Nanomedicine. 2015 Jan 12;10:557-66. doi: 10.2147/IJN.S75090. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25609961 Free PMC article.
-
State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.Iran J Pharm Res. 2017 Fall;16(4):1273-1304. Iran J Pharm Res. 2017. PMID: 29552041 Free PMC article. Review.
-
Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies.Curr Top Med Chem. 2024;24(14):1185-1211. doi: 10.2174/0115680266286460240220073334. Curr Top Med Chem. 2024. PMID: 38424436 Review.
-
Characterization of transgene expression and pDNA distribution of the suctioned kidney in mice.Drug Deliv. 2017 Nov;24(1):906-917. doi: 10.1080/10717544.2017.1333171. Drug Deliv. 2017. PMID: 28585867 Free PMC article.
-
Efficient gene transfection to the brain with ultrasound irradiation in mice using stabilized bubble lipopolyplexes prepared by the surface charge regulation method.Int J Nanomedicine. 2018 Apr 16;13:2309-2320. doi: 10.2147/IJN.S157375. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29713163 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources